Here are six insights:
1. StemCells reported the study Pathways’ mid-stage results at the 2016 American Spinal Injury Association meeting in Philadelphia.
2. Five patients of six patients in Cohort 1 demonstrated muscle strength improvements at six months.
3. Four patients of six patients exhibited enhanced performance on dexterity and fine motor skills test.
4. Four patients of six patients demonstrated improvement in the level of cord injury measured by the International Standards for Neurological Classification of SCI.
5. The company will report 12-month data later this quarter.
6. StemCells has enrolled 19 patients of 40 patients in the study. They expect to complete the study in 2017.
More articles on spine:
Mastering microsurgical, navigation for successful minimally invasive spine (MIS) surgery — Dr. Roger Härtl’s insight
10 spine, neurosurgeons on the move in March 2016
Drs. Vincent Wang, Peter Jannetta & more: 3 spine, neurosurgeons in the headlines this week — April 15, 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.